Confident in its association with the E.F.S. (Etablissement Français du Sang : French Blood Service) and its 30 year-long experience, DIAGAST today represents the perfect partner regarding transfusion compatibility. At the basis of this success is great know-how in Immunohematology enriched by a collective will for development, perpetual research and innovation.
DIAGAST has the solutions to meet customers' expectations. Its reagents ranges meet the needs of your laboratory whatever its activity. For the last 2 years, the Research and Development team has grown stronger and now acts as a real drive in the company.

In a push for constant evolution, the Research and Development department quickly developed E.M.^® Technology, and now leads the major R&D projects in collaboration with many organizations whose reputation has already been established and particularly E.F.S., INSERM (National Institute for Health and Medical Research), CNRS (National Center for Scientific Research).
The integration of new technology has shown our profession has evolved over the last 20 years.

From the reagents stage, we passed to "reagents integrated into automates". New clones, more reliable instruments and more accurate software contributed to making diagnosis computerised and safer.
To achieve this high level of performance, we have had to integrate new fields such as electronics, computer science and training; and this from the innovation stage.
It is crucial to think "system", evolving from the reagent to the outcome, via automates, interpretation software and the biologist's training in these new techniques.